✦ LIBER ✦

622 Efficacy and safety of peginterferon alpha-2a (40KD) [PEG] plus ribavirin [RBV] 1000/1200 mg/d in genotype 1 patients with chronic hepatitis C and ‘normal’ ALT levels

✍ Scribed by E. Zehnter; S. Mauss; C. John; R. Heyne; B. Möller; T. Lutz; B. Bokemeyer; R. Kihn; G. Moog; U. Alshuth; D. Hüppe

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predicting efficacy and safety outcomes

✍ Eric Snoeck; Stephanos J. Hadziyannis; Claudio Puoti; Mark G. Swain; Thomas Berg 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB

M1794 Efficacy and Tolerability of Pegin

✍ Hueppe, Dietrich; Zehnter, Elmar; Mauss, Stefan; Kaiser, Stephan; Schober, Andre 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 127 KB

P.241 Treatment outcomes in patients wit

✍ S. Zeuzem; P. Marcellin; P. Pockros; N. Gitlin; P. Farci; M. Shiffman; J. Zarski 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 145 KB

568 Efficacy and safety of the treatment

✍ M. Diago; J. Boadas; R. Planasi; R. Solá; J.A. del Olmo; J. Crespo; J.C. Erdozai 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 134 KB

503 Early prediction of sustained virolo

✍ P.J. Pockros; M. Diago; E. Gane; K.R. Reddy; D. Prati; M.L. Shiffman; P. Farci; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 65 KB

187 Efficacy and safety of 22 weeks of m

✍ Jean-Pierre Bronowicki; Denis Ouzan; Arnaud Tzanck; Tarik Asselah; Herve Desmora 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB